Adaptive Biotechnologies Corporation (ADPT)

Adaptive Biotechnologies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	50.65	47.92	65.06	90.03	139.07	123.44
Short-Term Investments	142.78	174.37	281.34	408.17	214	564.83
Cash & Short-Term Investments	193.42	222.29	346.4	498.2	353.06	688.27
Cash Growth	-37.38%	-35.83%	-30.47%	41.11%	-48.70%	19.31%
Accounts Receivable	43.58	41.73	37.97	40.06	17.41	10.05
Other Receivables	1.5	1.3	1	0.8	1.4	2.5
Receivables	45.08	43.03	38.97	40.86	18.81	12.55
Inventory	8.68	8.44	14.45	14.45	19.26	14.06
Prepaid Expenses	9.3	9.99	10.37	8.64	11.62	12.04
Total Current Assets	256.49	283.75	410.19	562.15	402.75	726.91
Property, Plant & Equipment	88.43	94.38	120.32	164.21	172.94	139.04
Long-Term Investments	39.36	33.66	-	-	217.15	118.53
Goodwill	118.97	118.97	118.97	118.97	118.97	118.97
Other Intangible Assets	3.01	3.43	5.13	6.83	8.53	10.23
Other Long-Term Assets	4.6	5.18	6.52	4.46	3.01	2.74
Total Assets	510.85	539.38	661.13	856.62	923.34	1,116
Accounts Payable	6.36	7.27	7.72	8.08	3.31	3.24
Accrued Expenses	14.17	20.67	20.39	24.1	22.2	18.92
Current Portion of Long-Term Debt	2.01	0.87	-	-	-	-
Current Portion of Leases	10.46	10.24	9.38	9.23	5.06	3.53
Current Income Taxes Payable	-	0.18	0.06	0.19	0.39	0.37
Current Unearned Revenue	54.81	55.69	48.63	64.12	80.46	73.32
Other Current Liabilities	-	3.15	1.84	4.07	2.39	5.82
Total Current Liabilities	87.81	98.05	88.02	109.79	113.81	105.2
Long-Term Debt	131.55	132.41	130.66	125.36	-	-
Long-Term Leases	76.44	79.15	89.39	98.77	106.69	104.33
Long-Term Unearned Revenue	24.81	27.26	44.79	58.6	98.75	163.62
Other Long-Term Liabilities	0.02	0.02	-	-	-	-
Total Liabilities	320.63	336.89	352.86	392.52	319.24	373.15
Common Stock	0.02	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,524	1,506	1,453	1,387	1,324	1,254
Retained Earnings	-1,334	-1,304	-1,144	-919.08	-718.89	-511.61
Comprehensive Income & Other	0.13	0.17	0.22	-4.12	-1.14	0.89
Total Common Equity	190.42	202.71	308.4	464.17	603.99	743.27
Minority Interest	-0.2	-0.22	-0.12	-0.07	0.11	-
Shareholders' Equity	190.22	202.49	308.28	464.1	604.1	743.27
Total Liabilities & Equity	510.85	539.38	661.13	856.62	923.34	1,116
Total Debt	220.46	222.67	229.43	233.36	111.74	107.86
Net Cash (Debt)	12.32	33.29	116.97	264.83	458.47	698.93
Net Cash Growth	-84.76%	-71.54%	-55.83%	-42.23%	-34.41%	8.24%
Net Cash Per Share	0.08	0.23	0.81	1.86	3.27	5.33
Filing Date Shares Outstanding	151.92	148.58	145.09	143.23	141.58	139.22
Total Common Shares Outstanding	151.92	147.77	145.08	143.11	141.39	137.65
Working Capital	168.68	185.7	322.17	452.36	288.94	621.72
Book Value Per Share	1.25	1.37	2.13	3.24	4.27	5.40
Tangible Book Value	68.45	80.31	184.3	338.37	476.49	614.07
Tangible Book Value Per Share	0.45	0.54	1.27	2.36	3.37	4.46
Machinery	-	59.33	61.36	56.7	48.88	34.08
Construction In Progress	-	2.57	3.41	7.63	5.66	7.19
Leasehold Improvements	-	73.28	74.73	72.4	65.96	21.95

Updated May 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q